510(k) Report

510(k) · Cleared

Cleared

ILO292 DP Echoport Plus Oae System

K983351510(k) TraditionalCleared Dec 11, 199879-day reviewClass II21 CFR 874.1050

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Otodynamics, Ltd. · EWO Audiometer

Cleared on Dec 11, 1998 after a 79-day review. FDA’s file for it is a 510(k) statement, which names no predicate.

Decided
Dec 11, 1998
Review
79 days
Class
Class II
Product code
EWO
Recalls
None
Predicates
0

FDA’s file for it is a 510(k) statement, which names no predicate.

FIG. 1 — Lineage of K983351Source: FDA 510(k) database · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA 510(k) statement (indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in EWO? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new EWO device

  1. #1 K234095 OtoNova/OtoNova Proscore 9.3 · 7 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against?

FDA’s file for it is a 510(k) statement, which names no predicate.

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

How does its category compare?

All EWO devices

EWO Audiometer: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · EWO

2in 2024

2007: 52008: 12009: 22010: 22011: 32012: 42013: 22014: 12015: 42017: 22018: 22019: 12022: 12023: 12024: 2
2007high 5 (2007) · low 0 (2016)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · EWO

173in 2015

2007: 69 days median2011: 151 days median2012: 137 days median2015: 173 days median
2007high 173 (2015) · low 69 (2007)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · EWO

4in 2023

2008: 12023: 4
2007high 4 (2023) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · EWO

13in 2025

2007: 12008: 12009: 12010: 42011: 22015: 12019: 62020: 72021: 32022: 62023: 32024: 22025: 13
2007high 13 (2025) · low 0 (2012)2025

MAUDE reports naming product code EWO, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
200756901
20081—11
20092—01
20102—04
2011315102
2012413700
20132—00
20141—00
2015417301
20160—00
20172—00
20182—00
20191—06
20200—07
20210—03
20221—06
20231—43
20242—02
20250—013
20260—0—

What is it indicated for?

The Otodynamics IL0O292 DP ECHOPORTplus system performs an auditory screening function by objectively testing for normal function of the cochlea. It is a new concept in OAE screening and analysis since it operates in standalone mode, without a PC. It is based on the DP ECHOPORT Instrument but with added built-in processor and graphic display. Otodynamics IL0O292 DP ECHOPORTplus system provides DPOAE facilities in addition to all the screening and TEOAE…

Read the full statement (133 words)

The Otodynamics IL0O292 DP ECHOPORTplus system performs an auditory screening function by objectively testing for normal function of the cochlea. It is a new concept in OAE screening and analysis since it operates in standalone mode, without a PC. It is based on the DP ECHOPORT Instrument but with added built-in processor and graphic display.

Otodynamics IL0O292 DP ECHOPORTplus system provides DPOAE facilities in addition to all the screening and TEOAE functions of the ECHOPORTplus. Both TEOAE’s and DPOAE’s are useful as screening tests for cochlear function in infants, children and adults. They are particularly useful when the patient is unable to respond

DPOAE’s are useful with older patients, as the method can tolerate sub-clinical depression of cochlear activity. DPOAE’s are also of use to test the higher frequency region of the cochlea.

Indications for use read by OCR from a scanned FDA 510(k) statement, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K983351: ILO292 DP Echoport Plus Oae System.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 5, 2026. https://510kreport.com/device/K983351

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Page last updated Nov 3, 2026